Whilst the focus is on SR-aGVHD BLA resubmission this quarter, for anyone who heard the recent presentation was there any clarification regarding timing on FDA meeting for paediatric congenital heart disease? The half yearly presentation had target of Q2 CY2024, but this latest presentation just has MESO plans to meet, which to me implies yet to be scheduled and therefore unlikely this quarter, thanks.
Whilst the focus is on SR-aGVHD BLA resubmission this quarter,...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |